National and Kapodistrian University of Athens
Ανίχνευση μεταλλάξεων στο γονίδιο του παράγοντα VIII σε παιδιά με βαριά αιμορροφιλία Α
Abstract
dc:descriptionHaemophilia A is the most common X-linked bleeding disorder which is caused by a spectrum of mutations in the factor VIII gene (FVIII). Point mutations, deletions and insertions have been detected in all 26 exons of the FVIII gene of Haemophilia A patients and cause phenotypes of variable severity. Most mutations are individual ones but some variants are recurrent because they occur at specific hot spots. Two types of recurrent inversions in the FVIII gene are known to cause severe haemophilia A: intron 22 and intron 1 inversions with an incidence of 40-50% and 2-5%, respectively. The type of mutation plays an important role in the FVIII inhibitor formation. The aim of the present study was to determine the spectrum of mutations in the FVIII gene in patients with severe haemophilia A. Genomic DNA samples of 96 unrelated severe haemophilia A children were analyzed by Southern blotting and Long-Distance PCR for the detection of intron 22 inversion. Two complementary multiplex PCRs were used for the detection of intron 1 inversion in patients without intron 22 inversion. Direct sequencing of the coding region of the FVIII gene was used to identify the mutations in 14 unrelated patients who were negative for both inversions. The sequences were compared with the (HAMSTeRs;http:hadb.org.uk) database. The intron 22 inversion occurred in 50% (48/96) of patients with severe haemophilia A in the present study. All patients tested for intron 1 inversion were negative for this mutation. Direct sequencing of the coding regions and the exon /intron bounderies of FVIII gene revealed 13 different mutations, and five had not been previously described in the international database which supports the diversity of FVIII gene mutation. These novel mutations included one large deletion, two small deletions, one nonsense and one splice-site mutation. Among the 13 mutations, four were nonsense, one was large deletion four were small deletions, two were missense and two were splice-site mutations. Five patients out of the 13 developed FVIII inhibitors, one patient with large deletion, two patients with small deletions and two patients with nonsense mutations. Also, in the patients with intron 22 inversion the occurrence of inhibitor-positive cases was 34% and the clinical phenotype in 92% of patients was severe. Knowledge of the disease-causing mutation may have clinical significance for appropriate patient management, as it may help predict patients at risk of developing inhibitors to FVIII replacement therapy. It may also accurately determine the carrier status of at risk family members and prenatal diagnosis.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kapsimali, Zoi
- Καψιμάλη, Ζωή
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/41394